ArticleKidney international reports2019

Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis.

Carlos Adrián Chávez-Mendoza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.